What did @ruby.fremon actually say?
She made several layered claims about kambo, the secretion from the giant monkey frog Phyllomedusa bicolor. The headline claims: over 40 years of scientific research exists on kambo, more than 70 pharmaceutical patents are pending to isolate its peptides, pharmaceutical companies want a synthesized pill version to replace kambo, and personally, kambo helped her with PTSD, depression, anxiety, sleep, hormones, and an autoimmune condition. She also said her "autoimmune marker just appears from my blood test. It's just gone." That last claim is the one that should stop you cold.
To be fair, kambo does contain real bioactive peptides. Phyllocaerulein, deltorphins, dermorphin, and phyllokinin are well-documented components. There is legitimate scientific curiosity about them. But scientific curiosity is not the same as clinical evidence that kambo cures, resolves, or eliminates autoimmune disease.
Does the science back this up?
Partially, on the peptide research side. Mostly no, on the personal health claims.
Kambo's peptide content has been studied since at least the 1980s. Vittorio Erspamer, the Italian pharmacologist who identified many of these compounds, published work on Phyllomedusa secretions in the 1980s and 1990s. Patent activity around these peptides is real. Dermorphin, for example, has been explored as an opioid receptor agonist with pharmaceutical potential (Negri et al., 1981, FEBS Letters). Phyllokinin has bradykinin-like activity studied in cardiovascular contexts.
But there are no peer-reviewed randomized controlled trials showing kambo administration resolves autoimmune markers in humans. None. The existing human-relevant data is largely case reports, and several of those are adverse event reports. A 2018 case series in Toxicon (Leban et al.) documented serious complications including hyponatremia, seizures, and death associated with kambo ceremonies. The peptide science is interesting. The clinical safety-and-efficacy data for humans is not there.
What did they get wrong (or right)?
Credit where it is due: the claim that pharmaceutical companies are interested in synthesizing kambo peptides is essentially accurate. That is how drug discovery often works, identifying bioactive compounds in nature and attempting to replicate them synthetically. The patent landscape around frog-derived peptides is documented. Calling this a profit motive is a reasonable observation, not a conspiracy theory.
What is wrong, and significantly so, is the autoimmune claim. Saying an "autoimmune marker just appears from my blood test, it's just gone" after kambo is an extraordinary medical claim with no controlled evidence behind it. Autoimmune markers fluctuate. Lab values change based on inflammation levels, timing of the test, lab variability, and dozens of other factors. Attributing the disappearance of a marker to kambo without controlled conditions is not evidence. It is a personal anecdote dressed up as proof.
The PTSD and depression claims also exceed what the evidence supports. There is theoretical interest in some kambo peptides for neurological applications, but no clinical trials in humans establishing efficacy for PTSD or depression specifically from kambo ceremonies.
What should you actually know?
Kambo is not a regulated therapeutic in the United States. It is not FDA-approved for any condition. Administering it involves burning the skin and applying the secretion to the wound, a practice associated with documented adverse events including vomiting, tachycardia, hypotension, and in rare cases death.
The peptides in kambo are genuinely interesting to researchers. That does not make kambo ceremonies safe or effective medical treatment. The gap between "these molecules have interesting biological activity" and "sitting with kambo regularly eliminates your autoimmune condition" is enormous, and that gap is filled with human risk, not evidence.
If you are managing an autoimmune condition, changes in your lab markers should be discussed with a licensed rheumatologist or immunologist, not attributed to a ceremony based on one person's self-reported blood test results. FormBlends works within regulated frameworks for bioactive peptide therapies precisely because the difference between a promising compound and a safe, evidence-backed therapy requires that rigor.